Paratek Pharmaceuticals Total Assets 2006-2019 | PRTK

Paratek Pharmaceuticals total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Paratek Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $300
2017 $164
2016 $136
2015 $146
2014 $110
2013 $1
2012 $98
2011 $69
2010 $74
2009 $95
2008 $14
2007 $110
2006 $66
2005 $52
Paratek Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q3 2019 $253
Q2 2019 $277
Q1 2019 $272
Q4 2018 $300
Q3 2018 $318
Q2 2018 $328
Q1 2018 $191
Q4 2017 $164
Q3 2017 $170
Q2 2017 $182
Q1 2017 $147
Q4 2016 $136
Q3 2016 $132
Q2 2016 $159
Q1 2016 $123
Q4 2015 $146
Q3 2015 $161
Q2 2015 $160
Q1 2015 $100
Q4 2014 $110
Q3 2014 $37
Q2 2014 $44
Q1 2014 $71
Q4 2013 $1
Q3 2013 $79
Q2 2013 $81
Q1 2013 $88
Q4 2012 $98
Q3 2012 $104
Q2 2012 $98
Q1 2012 $65
Q4 2011 $69
Q3 2011 $59
Q2 2011 $65
Q1 2011 $69
Q4 2010 $74
Q3 2010 $80
Q2 2010 $85
Q1 2010 $90
Q4 2009 $95
Q3 2009 $100
Q2 2009 $81
Q1 2009 $88
Q4 2008 $14
Q3 2008 $92
Q2 2008 $98
Q1 2008 $105
Q4 2007 $110
Q3 2007 $113
Q2 2007 $108
Q1 2007 $58
Q4 2006 $66
Q3 2006 $73
Q2 2006 $79
Q1 2006 $47
Q4 2005 $52
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.104B $0.017B
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics that treat infectious disease agents. The Company's lead product candidate, omadacycline, is a tetracycline-derived antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. Its second product candidate, WC 3035 is a tetracycline-derived compound designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals, Inc., formerly known as Transcept Pharmaceuticals, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.045B 16.02
CSL (CSLLY) Australia $87.810B 0.00
Gilead Sciences (GILD) United States $85.752B 10.62
Vertex Pharmaceuticals (VRTX) United States $56.573B 57.74
Biogen (BIIB) United States $52.731B 9.05
Illumina (ILMN) United States $47.124B 51.71
Regeneron Pharmaceuticals (REGN) United States $41.011B 17.96
Alexion Pharmaceuticals (ALXN) United States $24.231B 11.97
Incyte (INCY) United States $20.448B 47.47
Seattle Genetics (SGEN) United States $19.082B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.114B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.149B 0.00
Genmab (GNMSF) Denmark $14.038B 62.00
Alnylam Pharmaceuticals (ALNY) United States $13.244B 0.00
Galapagos (GLPG) Belgium $11.786B 30.37
Exact Sciences (EXAS) United States $11.058B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.267B 49.28
QIAGEN (QGEN) Netherlands $9.336B 30.44
BeiGene (BGNE) Cayman Islands $8.641B 0.00
Bio-Techne Corp (TECH) United States $8.220B 55.02
Amarin (AMRN) Ireland $8.148B 0.00
Sarepta Therapeutics (SRPT) United States $7.562B 0.00
BioNTech SE (BNTX) Germany $7.082B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.933B 0.00
Medicines (MDCO) United States $6.702B 0.00
Guardant Health (GH) United States $6.647B 0.00
Moderna (MRNA) United States $6.215B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.041B 15.36
Reata Pharmaceuticals (RETA) United States $6.040B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.961B 0.00
Exelixis (EXEL) United States $5.351B 15.05
Bluebird Bio (BLUE) United States $4.812B 0.00
Repligen (RGEN) United States $4.725B 85.63
Ascendis Pharma (ASND) Denmark $4.637B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.380B 0.00
Spark Therapeutics (ONCE) United States $4.273B 0.00
Mirati Therapeutics (MRTX) United States $4.170B 0.00
Immunomedics (IMMU) United States $4.008B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.907B 0.00
Adaptive Biotechnologies (ADPT) United States $3.770B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.624B 0.00
Blueprint Medicines (BPMC) United States $3.582B 0.00
Alkermes (ALKS) Ireland $3.297B 0.00
MyoKardia (MYOK) United States $3.045B 0.00
Genmab (GMAB) Denmark $2.956B 6.09
UniQure (QURE) Netherlands $2.854B 0.00
Emergent Biosolutions (EBS) United States $2.753B 27.34
Halozyme Therapeutics (HALO) United States $2.746B 0.00
NeoGenomics (NEO) United States $2.741B 145.83
Acceleron Pharma (XLRN) United States $2.616B 0.00
Zai Lab (ZLAB) China $2.435B 0.00
Amicus Therapeutics (FOLD) United States $2.409B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.367B 0.00
Arena Pharmaceuticals (ARNA) United States $2.350B 5.47
RA PHARMCTL INC (RARX) United States $2.231B 0.00
Insmed (INSM) United States $2.038B 0.00
Ligand Pharmaceuticals (LGND) United States $1.830B 35.21
Myriad Genetics (MYGN) United States $1.827B 26.99
Dicerna Pharmaceuticals (DRNA) United States $1.788B 0.00
Akcea Therapeutics (AKCA) United States $1.763B 0.00
Denali Therapeutics (DNLI) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.663B 0.00
Epizyme (EPZM) United States $1.648B 0.00
Principia Biopharma (PRNB) United States $1.614B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.556B 0.00
Editas Medicine (EDIT) United States $1.518B 0.00
REGENXBIO (RGNX) United States $1.490B 0.00
Arvinas (ARVN) United States $1.446B 0.00
Fate Therapeutics (FATE) United States $1.412B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.387B 0.00
Innoviva (INVA) United States $1.353B 3.99
Athenex (ATNX) United States $1.342B 0.00
Alector (ALEC) United States $1.317B 0.00
Coherus BioSciences (CHRS) United States $1.255B 0.00
WAVE Life Sciences (WVE) Singapore $1.225B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.079B 0.00
Pharming Group (PHGUF) Netherlands $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.002B 0.00
Zealand Pharma (ZEAL) Denmark $0.986B 0.00
Codexis (CDXS) United States $0.912B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.889B 7.48
ZIOPHARM Oncology Inc (ZIOP) United States $0.876B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.867B 0.00
Twist Bioscience (TWST) United States $0.855B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.824B 0.00
Intellia Therapeutics (NTLA) United States $0.806B 0.00
Vericel (VCEL) United States $0.797B 297.33
MiMedx (MDXG) United States $0.783B 0.00
Anika Therapeutics (ANIK) United States $0.774B 25.12
Heska (HSKA) United States $0.745B 190.26
DBV Technologies S.A (DBVT) France $0.738B 0.00
Revance Therapeutics (RVNC) United States $0.735B 0.00
ANI Pharmaceuticals (ANIP) United States $0.731B 12.47
UROGEN PHARMA (URGN) United States $0.707B 0.00
Adverum Biotechnologies (ADVM) United States $0.691B 0.00
Sorrento Therapeutics (SRNE) United States $0.684B 0.00
Intra-Cellular Therapies (ITCI) United States $0.671B 0.00
Cellectis S.A (CLLS) France $0.669B 0.00
Cara Therapeutics (CARA) United States $0.654B 0.00
Mesoblast (MESO) Australia $0.650B 0.00
Kadmon Holdings (KDMN) United States $0.646B 0.00
Clovis Oncology (CLVS) United States $0.642B 0.00
GENFIT S.A (GNFT) France $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Retrophin (RTRX) United States $0.579B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 13.33
BioDelivery Sciences (BDSI) United States $0.569B 0.00
PHARMA MAR SA (PHMMF) Spain $0.569B 0.00
Cytokineticsorporated (CYTK) United States $0.562B 0.00
Dynavax Technologies (DVAX) United States $0.554B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.550B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.537B 3.71
Agenus (AGEN) United States $0.533B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Precision BioSciences (DTIL) United States $0.499B 0.00
Prothena (PRTA) Ireland $0.499B 0.00
Stemline Therapeutics (STML) United States $0.488B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Gritstone Oncology (GRTS) United States $0.416B 0.00
AnaptysBio (ANAB) United States $0.412B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.404B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
PDL BioPharma (PDLI) United States $0.397B 9.94
Bellus Health (BLU) Canada $0.387B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.373B 0.00
OSMOTICA PHARM (OSMT) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.346B 0.00
Pfenex (PFNX) United States $0.340B 0.00
Puma Biotechnology (PBYI) United States $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.320B 0.00
Starpharma Holdings (SPHRY) Australia $0.311B 0.00
Kindred Biosciences (KIN) United States $0.310B 0.00
Kamada (KMDA) Israel $0.304B 8.87
CytomX Therapeutics (CTMX) United States $0.301B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.298B 0.00
Compugen (CGEN) Israel $0.298B 0.00
Scholar Rock Holding (SRRK) United States $0.297B 0.00
Geron (GERN) United States $0.294B 0.00
Cue Biopharma (CUE) United States $0.292B 0.00
Seres Therapeutics (MCRB) United States $0.286B 0.00
Senesco Technologies (ELOX) United States $0.280B 0.00
MannKind (MNKD) United States $0.279B 0.00
Albireo Pharma (ALBO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.269B 0.00
Inovio Pharmaceuticals (INO) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Exicure (XCUR) United States $0.241B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.238B 0.00
ChromaDex (CDXC) United States $0.238B 0.00
IVERIC Bio (ISEE) United States $0.235B 0.00
Theratechnologies (THTX) Canada $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.229B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.218B 0.00
Spero Therapeutics (SPRO) United States $0.211B 0.00
XOMA (XOMA) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Athersys (ATHX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.197B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.194B 0.00
Protagonist Therapeutics (PTGX) United States $0.193B 0.00
NantKwest (NK) United States $0.189B 0.00
Mersana Therapeutics (MRSN) United States $0.188B 0.00
Palatin Technologies (PTN) United States $0.185B 5.06
ARAVIVE, INC (ARAV) United States $0.184B 0.00
Cerecor (CERC) United States $0.184B 0.00
Affimed (AFMD) Germany $0.175B 0.00
Five Prime Therapeutics (FPRX) United States $0.164B 0.00
Alcobra (ARCT) United States $0.164B 0.00
VBI Vaccines (VBIV) United States $0.163B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Dyadic (DYAI) United States $0.157B 0.00
Windtree Therapeutics (WINT) United States $0.148B 0.00
Aptinyx (APTX) United States $0.141B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.140B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.137B 0.00
Arsanis (XFOR) United States $0.137B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
TELA Bio (TELA) United States $0.130B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Novavax (NVAX) United States $0.109B 0.00
Menlo Therapeutics (MNLO) United States $0.108B 0.00
Celyad SA (CYAD) Belgium $0.107B 0.00
Verastem (VSTM) United States $0.107B 0.00
BioTime (LCTX) United States $0.105B 5.39
Strongbridge Biopharma (SBBP) United States $0.097B 2.59
Aduro Biotech (ADRO) United States $0.094B 0.00
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
Synlogic (SYBX) United States $0.091B 0.00
Antibe Therapeutics (ATBPF) Canada $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
OvaScience (MLND) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.078B 0.00
Liquidia Technologies (LQDA) United States $0.073B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.067B 0.00
Trevena (TRVN) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Curis (CRIS) United States $0.052B 0.00
Applied Genetic Technologies (AGTC) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
Alimera Sciences (ALIM) United States $0.047B 0.00
Protalix BioTherapeutics (PLX) Israel $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Checkpoint Therapeutics (CKPT) United States $0.045B 0.00
Orgenesis (ORGS) United States $0.043B 2.78
Vascular Biogenics (VBLT) Israel $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
AIT Therapeutics (XAIR) United States $0.040B 0.00
DiaMedica Therapeutics (DMAC) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Celsion (CLSN) United States $0.034B 0.00
Evogene (EVGN) Israel $0.034B 0.00
Stellar Biotechnologies (EDSA) Canada $0.034B 0.00
Apricus Biosciences (SEEL) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Novogen (KZIA) Australia $0.027B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Soligenix (SNGX) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00